Medtech Execs On The Move, June-July 2014
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
You may also be interested in...
Eric Compton, a rising industry executive is set to take the helm at the hemostatic device-maker Z-Medica. He follows in the footsteps of President and CEO Stephen Fanning.
Lilly announced it signed strategic international agreements with four diabetes companies to advance connected solutions and streamline care for people with diabetes in markets outside of the US.
Three firms launched initial public offerings during the first week of May, but Gyroscope postponed its IPO while Jasper, Science 37 and Roivant took the special purpose acquisition corporation route.